Doximity, a leading digital platform for medical professionals, reported strong third-quarter fiscal 2025 results, exceeding analysts' revenue and guidance expectations. The company raised its full-year revenue guidance, citing record engagement and significant growth in its AI tools.
Doximity , a leading digital platform for medical professionals, announced its third-quarter fiscal 2025 results, exceeding analysts' projections for both revenue and guidance. The company raised its full-fiscal-year revenue forecast from a previous range of $535 million to $540 million to a new range of $564.6 million to $565.6 million.
Doximity facilitates a wide range of services for clinicians, including access to medical news, streamlined paperwork management, referral services, and telehealth appointments with patients. Its primary revenue streams stem from telehealth tools, recruitment solutions, and marketing offerings targeted at clients in the pharmaceutical industry. Doximity's third-quarter revenue surged by 25% compared to the same period last year, reaching $135.3 million. Looking ahead to its fiscal fourth quarter, the company anticipates revenue between $132.5 million and $133.5 million, surpassing analysts' estimates of $123.8 million. Notably, Doximity's CEO, Jeff Tangney, highlighted the platform's record engagement in the third quarter, with over 610,000 unique providers utilizing its clinical workflow tools. The company's AI tools experienced the most significant growth, expanding by 60% compared to the previous quarter, while its newsfeed attracted over one million unique providers. During the third quarter, Doximity reported a net income of $75.2 million, or 37 cents per share, marking a substantial increase from $48.0 million, or 24 cents per share, in the year-ago period. Adjusted EBITDA reached $102.0 million, reflecting a 39% year-over-year surge. These impressive financial results demonstrate Doximity's resilience in a challenging economic landscape, particularly within the technology sector, which has been grappling with a slowdown in growth. Doximity's stock price has more than doubled in 2024, illustrating investor confidence in its continued success
Doximity Healthcare Technology Telehealth AI Revenue Growth Digital Platform
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Under Armour Surpasses Expectations, Raises Outlook for Fiscal YearUnder Armour reported strong third-quarter earnings, exceeding analyst expectations and prompting an upward revision of the company's fiscal year outlook. Revenue declined slightly, but key metrics like adjusted operating income and international sales showed positive signs. CEO Stephanie Linnartz highlighted the company's focus on brand strengthening, product strategy, and a new marketing initiative.
Read more »
Mufasa: The Lion King Surpasses Expectations, Becomes One of 2024's Highest-Grossing FilmsMufasa: The Lion King, despite a slow start at the box office, has experienced a significant resurgence, reaching impressive milestones. The film has crossed $170 million domestically and $307 million internationally, bringing its global total to $477 million. This places it among the top 10 highest-grossing movies of the year worldwide and within the top 15 highest-grossing musicals domestically.
Read more »
Nicole Kidman's 'Babygirl' Surpasses Expectations at the Box OfficeDespite facing stiff competition from major releases like 'Mufasa: The Lion King' and 'Sonic the Hedgehog 3', Nicole Kidman's 'Babygirl' has achieved notable box office success. The film has grossed over $26 million worldwide, placing it among A24's highest-grossing movies. 'Babygirl' has performed well despite a limited theatrical release, demonstrating its appeal to audiences.
Read more »
Bank of America Surpasses Q4 Expectations, Shares RiseBank of America reported strong fourth-quarter fiscal 2024 results, exceeding analyst projections for revenue, net interest income, and return on assets. Shares increased about 2% in premarket trading.
Read more »
Box Office Upsets: 'One of Them Days' Surpasses Expectations, 'Wolf Man' DisappointsThe 2025 box office experiences a surprising weekend with 'Mufasa: The Lion King' reigning supreme, while 'One of Them Days' and 'Wolf Man' underperform. 'One of Them Days' receives critical acclaim, propelling it to second place, while 'Wolf Man' struggles to connect with audiences. The article analyzes the reasons behind these box office shifts, highlighting the importance of critical reception and audience response.
Read more »
Nicole Kidman's Babygirl Surpasses Expectations at the Box OfficeNicole Kidman's erotic thriller *Babygirl* continues to impress at the box office, despite facing strong competition from major releases. The film has grossed $30 million globally, with strong domestic performance.
Read more »